A new study suggests transgender women maintain an athletic advantage over their cisgender peers even after a year on hormone therapy.
The results, published last month in the British Journal of Sports Medicine, could mean the current one-year waiting period for Olympic athletes who are transitioning is inadequate.
“For the Olympic level, the elite level, I’d say probably two years is more realistic than one year,” said the study’s lead author, Dr. Timothy Roberts, a pediatrician and the director of the adolescent medicine training program at Children’s Mercy Hospital in Kansas City, Missouri. “At one year, the trans women on average still have an advantage over the cis women,” he said, referring to cisgender, or nontransgender, women.
Roberts began investigating the athletic performance of transgender men and women while in the Air Force, working under co-author and physician Lt. Col. Joshua Smalley at a clinic coordinating care for airmen beginning or continuing their gender transition.
Active duty service members are required to take a physical readiness test every six to 12 months. Roberts, Smalley and another co-author, Dr. Dale Ahrendt, realized they had access to robust data on service members before, during and after they started hormone replacement treatment.
The three physicians conducted a retrospective review of medical records and fitness tests for 29 transgender men and 46 transgender women from 2013 to 2018. The Air Force’s fitness assessment includes the number of pushups and situps performed in a minute, and the time required to run 1.5 miles.
They also had records on when the subjects started testosterone or estrogen, the type of hormone used and the number of days from when treatment began to when their hormone levels reached the normal adult range for a cisgender person.
Click here to read more.
SOURCE: NBC News, Dan Avery